CTABF News and Press, Canntab Therapeutics Ltd From 10/27/20

Delta, Kelowna, BC - October 27, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus ins...

Canntab to Launch in Australia and Participate in Australia's Largest Cannabis Research Study PR Newswire TORONTO, Oct. 26, 2020 TORONTO , Oct. 26, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the " Comp...

Toronto, Ontario--(Newsfile Corp. - October 19, 2020) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the " Company " or " Canntab "), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that the ...

Delta, Kelowna, BC - September 21, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus i...

Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets PR Newswire TORONTO, Sept. 21, 2020 TORONTO , Sept. 21, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the " Company " or " Canntab...

Canntab announces planned purchases of cannabis processing equipment and leasehold improvements Canada NewsWire TORONTO, Aug. 21, 2020 TORONTO , Aug. 21, 2020 /CNW/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the " Company " or " Cannt...

Originally appointed as an Advisor, Larry Latowsky now appointed as CEO of Canntab Therapeutics Limited ( OTCQB:CTABF ) , effective immediately. More news on: Canntab Therapeutics Limited, Healthcare stocks news, Read more ...

TORONTO , Aug. 19, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, announces that it has appointed Larry Latow...

Canntab Therapeutics ( OTCQB:CTABF +11.6% ) announces that it has begun the production of its instant release tablets and has entered into its first purchase agreement with MediPharm Labs ( OTCQX:MEDIF ), a global leader in pharma quality cannabinoid based products. More news on: Cannt...

Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement Canada NewsWire TORONTO, June 2, 2020 TORONTO , June 2, 2020 /CNW/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the " Company " or " Canntab "), the leading innovat...